Relay Therapeutics, Inc.
NASDAQ: RLAY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Sanjiv K. Patel
- Employees
- 259
- Headquarters
- Cambridge, United States
- IPO year
- 2020
- Market cap
- $3.2B
- Website
- https://www.relaytx.com
Loading RLAY…
Loading profile data…Frequently asked questions about RLAY
What does Relay Therapeutics, Inc. (RLAY) do?
Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhancing the creation of small molecule therapies for specific types of cancer and genetic conditions. The company's pipeline features several promisin...
Where does RLAY trade?
Relay Therapeutics, Inc. (RLAY) trades on the NASDAQ Global Market.
What sector is RLAY in?
Relay Therapeutics, Inc. (RLAY) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Relay Therapeutics, Inc.?
Sanjiv K. Patel is the chief executive officer of Relay Therapeutics, Inc. (RLAY).
Where is Relay Therapeutics, Inc. headquartered?
Relay Therapeutics, Inc. is headquartered in United States.
Does RLAY pay a dividend?
Relay Therapeutics, Inc. (RLAY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RLAY go public?
Relay Therapeutics, Inc. (RLAY) completed its initial public offering in 2020.